Saleem Wael, LeQuang Jo Ann, Elayyan Muntaha, Rezk Mustafa, Fourati Zeineb, Hajaj Ahmad, Orompurath Mohammed, Jarallah Shaif, Coluzzi Flaminia, Pergolizzi Joseph V
Department of Anesthesiology/ICU and Perioperative Medicine, Hamad Medical Corporation, Doha P.O. BOX 3050, Qatar.
Department of Scientific Communication, NEMA Research, Naples, FL 34108, USA.
J Clin Med. 2025 Sep 5;14(17):6271. doi: 10.3390/jcm14176271.
The long-term implications of spinal interventional pain procedures (IPPs) remain underexplored. This study aimed to evaluate pain intensity, overall health quality, and disability over a four-year period following an IPP, while also assessing physical therapy (PT) compliance, the need for repeated procedures, and analgesic consumption. A prospective observational study with retrospective registration was conducted on patients with chronic spinal pain at Hamad Medical Corporation (HMC), Qatar. Patients were assessed using the Numeric Rating Scale (NRS), the Oswestry Disability Index (ODI), and the EuroQol 5-Dimension Index (EQ-5D). Additional tools included the EQ-Health Visual Analog Scale and the Patient Global Impression of Change (PGIC). Follow-ups were performed at 6, 12, 24, 36, and 48 months. A total of 766 patients were initially recruited, of whom 174 met the inclusion criteria. All patients demonstrated significant improvement across all outcome measures compared to the baseline. No significant differences were observed in pain or functional outcomes between PT-compliant and non-compliant groups. By the end of this study, 56.9% of patients reported reduced analgesic use, while 43.1% reported increased use. The patient satisfaction data showed that 55% (62/113) of those receiving a single IPP were satisfied, compared to 54% (33/61) in the multiple IPP group. The PGIC satisfaction scores revealed no statistically significant differences ( = 1). Overall health status, as measured by the EQ-5D Health scale, also showed no meaningful differences between groups. Despite several limitations, patients reported sustained improvement and satisfaction four years post-IPP. PT compliance did not appear to significantly influence long-term outcomes. Further research is needed to identify factors affecting post-IPP recovery and medication usage.
脊柱介入性疼痛治疗(IPPs)的长期影响仍未得到充分研究。本研究旨在评估IPPs治疗后四年内的疼痛强度、整体健康质量和残疾情况,同时评估物理治疗(PT)的依从性、重复治疗的必要性以及镇痛药的使用情况。在卡塔尔哈马德医疗公司(HMC)对慢性脊柱疼痛患者进行了一项带有回顾性登记的前瞻性观察研究。使用数字评分量表(NRS)、奥斯维斯特残疾指数(ODI)和欧洲五维健康量表(EQ-5D)对患者进行评估。其他工具包括EQ-健康视觉模拟量表和患者总体变化印象(PGIC)。在6、12、24、36和48个月时进行随访。最初共招募了766名患者,其中174名符合纳入标准。与基线相比,所有患者在所有结局指标上均有显著改善。在PT依从组和非依从组之间,疼痛或功能结局未观察到显著差异。到本研究结束时,56.9%的患者报告镇痛药使用减少,而43.1%的患者报告使用增加。患者满意度数据显示,接受单次IPPs治疗的患者中有55%(62/113)表示满意,而接受多次IPPs治疗的患者中这一比例为54%(33/61)。PGIC满意度评分未显示出统计学上的显著差异(=1)。用EQ-5D健康量表衡量的总体健康状况在各组之间也没有有意义的差异。尽管存在一些局限性,但患者在IPPs治疗后四年报告持续改善和满意。PT依从性似乎并未显著影响长期结局。需要进一步研究以确定影响IPPs治疗后恢复和药物使用的因素。